#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5045598	Binding	Inhibition of sigma 2 receptor (unknown origin) assessed as binding constant	Homo sapiens	17	ALA5042543	single protein format	Scientific Literature
2.	ALA5045600	Physicochemical	Aqueous solubility of the compound at pH 4		32	ALA5042543	small-molecule physicochemical format	Scientific Literature
3.	ALA5045601	Binding	Inhibition of fluorescent antagonist binding to human P2Y14R expressed in CHO cells preincubated for 30 mins followed by 6-amino-9-(2-carboxy-4-((6-(4-(4-(4-(4-(3-carboxy 6-(4-(trifluoromethyl)phenyl)naphthalen-1-yl)phenyl)piperidin-1-yl)butyl)-1H-1,2,3-triazol-1-yl)hexyl)carbamoyl)phenyl)-3-iminio-5-sulfo-3H-xanthene-4-sulfonate addition and measured after 30 mins by BD FACSCalibur flow cytometry analysis	Homo sapiens	40	ALA5042543	cell-based format	Scientific Literature
4.	ALA5045602	Physicochemical	Aqueous solubility of the compound at pH 7.4		32	ALA5042543	small-molecule physicochemical format	Scientific Literature
5.	ALA5045603	Physicochemical	Distribution coefficient, logD of compound at pH 7.4 by HPLC analysis		33	ALA5042543	small-molecule physicochemical format	Scientific Literature
6.	ALA5045604	Binding	Inhibition of fluorescent antagonist binding to mouse P2Y14R expressed in HEK293 cells preincubated for 30 mins followed by addition of 6-amino-9-(2-carboxy-4-((6-(4-(4-(4-(4-(3-carboxy-6-(4-(trifluoromethyl)phenyl)naphthalen-1-yl)phenyl)piperidin-1-yl)butyl)-1H-1,2,3-triazol-1-yl)hexyl)carbamoyl)phenyl)-3-iminio-5-sulfo-3H-xanthene-4-sulfonate incubated for 30 mins by BD FACSCalibur flow cytometry analysis	Mus musculus	10	ALA5042543	cell-based format	Scientific Literature
7.	ALA5045613	Binding	Inhibition of adrenergic alpha 2B receptor (unknown origin) assessed as binding constant	Homo sapiens	7	ALA5042543	single protein format	Scientific Literature
8.	ALA5045615	ADME	Stability of the compound in simulated intestinal fluid assessed as parent compound remaining at 120 mins		2	ALA5042543	assay format	Scientific Literature
9.	ALA5045616	ADME	Stability of the compound in simulated gastric fluid assessed as parent compound remaining at 120 mins by NMR analysis		2	ALA5042543	assay format	Scientific Literature
10.	ALA5045617	ADME	Inhibition of CYP1A2 (unknown origin)	Homo sapiens	2	ALA5042543	single protein format	Scientific Literature
11.	ALA5045618	ADME	Inhibition of CYP2C9 (unknown origin)	Homo sapiens	2	ALA5042543	single protein format	Scientific Literature
12.	ALA5045619	ADME	Inhibition of CYP2C19 (unknown origin)	Homo sapiens	2	ALA5042543	single protein format	Scientific Literature
13.	ALA5045620	ADME	Inhibition of CYP2D6 (unknown origin)	Homo sapiens	2	ALA5042543	single protein format	Scientific Literature
14.	ALA5045621	ADME	Inhibition of CYP3A4 (unknown origin)	Homo sapiens	2	ALA5042543	single protein format	Scientific Literature
15.	ALA5045622	ADME	Stability in rat plasma assessed as compound remaining after 120 mins	Rattus norvegicus	2	ALA5042543	cell-free format	Scientific Literature
16.	ALA5045623	ADME	Stability in mouse plasma assessed as compound remaining after 120 mins	Mus musculus	2	ALA5042543	cell-free format	Scientific Literature
17.	ALA5045624	ADME	Stability in mouse liver microsomes assessed as half life	Mus musculus	2	ALA5042543	microsome format	Scientific Literature
18.	ALA5045625	ADME	Stability in rat liver microsomes assessed as half life	Rattus norvegicus	2	ALA5042543	microsome format	Scientific Literature
19.	ALA5045626	ADME	Stability in human liver microsomes assessed as half life	Homo sapiens	2	ALA5042543	microsome format	Scientific Literature
20.	ALA5045627	Toxicity	Inhibition of hERG channel by patch clamp assay	Homo sapiens	2	ALA5042543	assay format	Scientific Literature